$AARD

$3.41▲ -13.7% YTD

4 SEC 13D/G filings tracked · Last updated Oct 23, 2026

Filing History

News

AARD ▼ -13.7% - Aardvark Therapeutics, Inc.

CP $3.41▲ -13.7%Oct 23, 2026 · ThinkSabio Blog

$AARD down pm…

News

AARD ▼ -13.7% - Aardvark Therapeutics, Inc.

CP $3.41▲ -13.7%Oct 23, 2026 · ThinkSabio Blog

$AARD - Aardvark Therapeutics Reports Exploratory Data from the Terminated HERO and Open-Label Extension Trials…

News

AARD ▼ -10.4% - Aardvark Therapeutics, Inc.

CP $3.95▲ -10.4%Oct 22, 2026 · ThinkSabio Blog

$AARD - Aardvark Therapeutics Announces FDA Has Lifted the Clinical Hold on ARD-101 for the Treatment of Prader-Willi Syndrome and Will Host Webcast t…

News

AARD ▲ +1.0% - Aardvark Therapeutics, Inc.

CP $4.96▲ +1.0%Oct 8, 2026 · ThinkSabio Blog

$AARD - Aardvark Therapeutics Appoints Clinical Development Leader David Zhang, Ph.D., MBA, to its Board of Directors…